Back to search

Article

A case of advanced biliary tract cancer with EGFR amplification that responded to Necitumumab and post-treatment resistance changes detected by liquid biopsy

2024-03-31

Abstract excerpt

<h4>Background: </h4> Recent advances in cancer genome analysis and the practice of precision medicine have made it possible to identify fractions with rare genetic alterations. EGFR -amplified cancers are known to be rare fractions across organs and have a poor prognosis. The use of anti-EGFR antibody for EGFR -amplified cancers has been promising, but the evidence is not yet clear. Case: In this report, we de...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2eb69c65-8fb5-500d-b1d7-949c10382145
DOI
10.22541/au.171189338.87013934/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A case of advanced biliary tract cancer with EGFR amplification that responded to Necitumumab and post-treatment resistance changes detected by liquid biopsyDOI 10.22541/au.171189338.87013934/v1
Select a neighboring publication to make it the new centre.